Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Respiratory Medicine Reviews
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1573-398X
  • E-ISSN: 1875-6387

Abstract

Background

Long-term impacts of inhaled corticosteroids (ICSs) on metabolic parameters of asthmatic children are still uncertain.

Objective

This study aimed to evaluate the effects of long-term use of ICSs on metabolic and anthropometric measures among children with asthma in Iran.

Methods

This case-control study was conducted among 200 pediatric asthmatic patients who were referred to Abuzar Hospital (Ahvaz, Iran) during nine months. Demographic and clinical data of the patients were recorded. The participants were categorized into two groups: Group 1 (n = 100) comprising children with moderate to severe asthma, and Group 2 (n = 100) consisting of those with mild asthma.

Results

The average age of 200 patients was 8.1 ± 2.9 years. The majority of them were male. The prevalence of wasting, stunting, obesity, and overweight was higher among Group 1 compared to Group 2 ( < 0.05). Patients in Group 1 had significantly higher levels of calcium, vitamin D, lipids, and glycemic parameters than those in Group 2 ( < 0.05). In addition, the duration of ICS use was notably longer in Group 1 ( < 0.05).

Conclusion

Children with moderate and severe asthma had significantly elevated lipid and glycemic parameters, as well as a higher prevalence of wasting, stunting, obesity, and overweight compared to patients with mild asthma. Further studies involving larger sample sizes and longer durations are necessary to confirm these findings.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X321966240816091814
2024-08-29
2025-06-26

  • From This Site

    /content/journals/crmr/10.2174/011573398X321966240816091814
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. FerranteG. La GruttaS. The burden of pediatric asthma.Front Pediatr.2018618610.3389/fped.2018.0018629988370
     [Google Scholar]
  2. AsherM.I. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study.Lancet20213981031115691580
     [Google Scholar]
  3. SerebriskyD. WizniaA. Pediatric asthma: A global epidemic.Ann. Glob. Health2019851610.5334/aogh.241630741507
     [Google Scholar]
  4. KuruvillaM.E. LeeF.E.H. LeeG.B. Understanding asthma phenotypes, endotypes, and mechanisms of disease.Clin. Rev. Allergy Immunol.201956221923310.1007/s12016‑018‑8712‑130206782
     [Google Scholar]
  5. RicciardoloF.L.M. SprioA.E. BarosoA. GalloF. RiccardiE. BertoliniF. CarrieroV. ArrigoE. CiprandiG. Characterization of T2-low and T2-high asthma phenotypes in real-life.Biomedicines2021911168410.3390/biomedicines911168434829913
     [Google Scholar]
  6. LicariA. CastagnoliR. BrambillaI. MarsegliaA. ToscaM.A. MarsegliaG.L. CiprandiG. Asthma endotyping and biomarkers in childhood asthma.Pediatr. Allergy Immunol. Pulmonol.2018312445510.1089/ped.2018.088630069422
     [Google Scholar]
  7. TrivediM. DentonE. Asthma in children and adults—what are the differences and what can they tell us about asthma?Front Pediatr.2019725610.3389/fped.2019.0025631294006
     [Google Scholar]
  8. AegerterH. LambrechtB.N. The pathology of asthma: What is obstructing our view?Annu. Rev. Pathol.202318138740910.1146/annurev‑pathol‑042220‑01590236270294
     [Google Scholar]
  9. MimsJ.W. Asthma: Definitions and pathophysiology.Int Forum Allergy Rhinol.20155Suppl 1S2610.1002/alr.21609
     [Google Scholar]
  10. PijnenburgM.W. FreyU. De JongsteJ.C. SaglaniS. Childhood asthma: Pathogenesis and phenotypes.Eur. Respir. J.2022596210073110.1183/13993003.00731‑202134711541
     [Google Scholar]
  11. HopkinJ.M. The diagnosis of asthma, a clinical syndrome.Thorax201267766066210.1136/thoraxjnl‑2012‑20182522561527
     [Google Scholar]
  12. WenzelS.E. Complex phenotypes in asthma: Current definitions.Pulm. Pharmacol. Ther.201326671071510.1016/j.pupt.2013.07.00323880027
     [Google Scholar]
  13. WisniewskiJ.A. A comparison of seasonal trends in asthma exacerbations among children from geographic regions with different climates.Allergy Asthma Proc.201637647548110.2500/aap.2016.37.3994
     [Google Scholar]
  14. LarsenK. ZhuJ. FeldmanL.Y. SimatovicJ. DellS. GershonA.S. ToT. The annual September peak in asthma exacerbation rates. Still a reality?Ann. Am. Thorac. Soc.201613223123910.1513/AnnalsATS.201508‑545OC26636481
     [Google Scholar]
  15. JacksonD.J. SykesA. MalliaP. JohnstonS.L. Asthma exacerbations: Origin, effect, and prevention.J. Allergy Clin. Immunol.201112861165117410.1016/j.jaci.2011.10.02422133317
     [Google Scholar]
  16. CastroC. TarabichiY. AyacheM. Seasonal trends in asthma exacerbations: Are they the same in asthma subgroups?Ann Allergy Asthma Immunol20191232220222
     [Google Scholar]
  17. NakagomeK. NagataM. Involvement and possible role of eosinophils in asthma exacerbation.Front. Immunol.20189222010.3389/fimmu.2018.0222030323811
     [Google Scholar]
  18. McBrienC.N. Menzies-GowA. The biology of eosinophils and their role in asthma.Front. Med. (Lausanne)201749310.3389/fmed.2017.0009328713812
     [Google Scholar]
  19. PoddigheD. MathiasC.B. BrambillaI. MarsegliaG.L. OettgenH.C. Importance of basophils in eosinophilic asthma: The murine counterpart.J. Biol. Regul. Homeost. Agents201832233533929685015
     [Google Scholar]
  20. HanJ. NguyenJ. KimY. GengB. RomanowskiG. AlejandroL. ProudfootJ. XuR. LeibelS. Effect of inhaled corticosteroid use on weight (BMI) in pediatric patients with moderate-severe asthma.J. Asthma201956326326910.1080/02770903.2018.145585329672188
     [Google Scholar]
  21. RamamoorthyS. CidlowskiJ.A. Corticosteroids.Rheum. Dis. Clin. North Am.20164211531, vii10.1016/j.rdc.2015.08.00226611548
     [Google Scholar]
  22. VandewalleJ. LuypaertA. De BosscherK. LibertC. Therapeutic mechanisms of glucocorticoids.Trends Endocrinol. Metab.2018291425410.1016/j.tem.2017.10.01029162310
     [Google Scholar]
  23. CoutinhoA.E. ChapmanK.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.Mol. Cell. Endocrinol.2011335121310.1016/j.mce.2010.04.00520398732
     [Google Scholar]
  24. KulkarniS. DurhamH. GloverL. AtherO. PhillipsV. NemesS. CousensL. BlomgranP. AmberyP. Metabolic adverse events associated with systemic corticosteroid therapy—A systematic review and meta-analysis.BMJ Open20221212e06147610.1136/bmjopen‑2022‑06147636549729
     [Google Scholar]
  25. Al EfraijK. JohnsonK.M. WiebeD. SadatsafaviM. FitzGeraldJ.M. A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.J. Asthma201956121334134610.1080/02770903.2018.153910030513226
     [Google Scholar]
  26. FardetL. FèveB. Systemic glucocorticoid therapy: A review of its metabolic and cardiovascular adverse events.Drugs201474151731174510.1007/s40265‑014‑0282‑925204470
     [Google Scholar]
  27. SpiesC.M. StrehlC. van der GoesM.C. BijlsmaJ.W.J. ButtgereitF. Glucocorticoids.Best Pract. Res. Clin. Rheumatol.201125689190010.1016/j.berh.2011.11.00222265268
     [Google Scholar]
  28. RiceJ.B. WhiteA.G. ScarpatiL.M. WanG. NelsonW.W. Long-term systemic corticosteroid exposure: A systematic literature review.Clin. Ther.201739112216222910.1016/j.clinthera.2017.09.01129055500
     [Google Scholar]
  29. SchäckeH. DöckeW-D. AsadullahK. Mechanisms involved in the side effects of glucocorticoids.Pharmacol. Ther.2002961234310.1016/S0163‑7258(02)00297‑812441176
     [Google Scholar]
  30. ChungK.F. WenzelS.E. BrozekJ.L. BushA. CastroM. SterkP.J. AdcockI.M. BatemanE.D. BelE.H. BleeckerE.R. BouletL.P. BrightlingC. ChanezP. DahlenS.E. DjukanovicR. FreyU. GagaM. GibsonP. HamidQ. JarjourN.N. MauadT. SorknessR.L. TeagueW.G. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.Eur. Respir. J.201443234337310.1183/09031936.0020201324337046
     [Google Scholar]
  31. KellyH.W. SternbergA.L. LescherR. FuhlbriggeA.L. WilliamsP. ZeigerR.S. RaissyH.H. Van NattaM.L. TonasciaJ. StrunkR.C. Effect of inhaled glucocorticoids in childhood on adult height.N. Engl. J. Med.20123671090491210.1056/NEJMoa120322922938716
     [Google Scholar]
  32. KapadiaC.R. NebesioT.D. MyersS.E. WilliS. MillerB.S. AllenD.B. Jacobson-DickmanE. Endocrine effects of inhaled corticosteroids in children.JAMA Pediatr.2016170216317010.1001/jamapediatrics.2015.352626720105
     [Google Scholar]
  33. DahlR. Systemic side effects of inhaled corticosteroids in patients with asthma.Respir. Med.200610081307131710.1016/j.rmed.2005.11.02016412623
     [Google Scholar]
  34. BindushaS. NairS. BeegumM.S. Glycosylated hemoglobin levels and lipid profile in children with asthma using low dose and high dose inhaled corticosteroids.Indian J. Allergy Asthma Immunol.2015291283110.4103/0972‑6691.162977
     [Google Scholar]
  35. ShangW. WangG. WangY. HanD. The safety of long-term use of inhaled corticosteroids in patients with asthma: A systematic review and meta-analysis.Clin. Immunol.202223610896010.1016/j.clim.2022.10896035218965
     [Google Scholar]
  36. HossnyE. RosarioN. LeeB.W. SinghM. El-GhoneimyD. SohJ.Y. Le SouefP. The use of inhaled corticosteroids in pediatric asthma: Update.World Allergy Organ. J.201692610.1186/s40413‑016‑0117‑027551328
     [Google Scholar]
  37. SwartzS.L. DluhyR.G. Corticosteroids.Drugs197816323825510.2165/00003495‑197816030‑00006209958
     [Google Scholar]
  38. VegiopoulosA. HerzigS. Glucocorticoids, metabolism and metabolic diseases.Mol. Cell. Endocrinol.20072751-2436110.1016/j.mce.2007.05.01517624658
     [Google Scholar]
  39. AkalestouE. GenserL. RutterG.A. Glucocorticoid metabolism in obesity and following weight loss.Front. Endocrinol. (Lausanne)2020115910.3389/fendo.2020.0005932153504
     [Google Scholar]
  40. SwarbrickM. ZhouH. SeibelM. Mechanisms in Endocrinology: Local and systemic effects of glucocorticoids on metabolism: New lessons from animal models.Eur. J. Endocrinol.20211855R113R12910.1530/EJE‑21‑055334478405
     [Google Scholar]
  41. MagomedovaL. CumminsC.L. Glucocorticoids and metabolic control.Metabolic ControlChamSpringer20167393
     [Google Scholar]
  42. DamiańskiP. KardasG. PanekM. KunaP. KupczykM. Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: Current progress and future directions.Expert Opin. Drug Saf.202221449951510.1080/14740338.2022.199992634720035
     [Google Scholar]
  43. ChippsB. Relative efficacy and safety of inhaled corticosteroids in patients with asthma: Systematic review and network meta-analysis.Ann Allergy Asthma Immunol.20201252163170.e3
     [Google Scholar]
  44. HefflerE. MadeiraL.N.G. FerrandoM. PuggioniF. RaccaF. MalvezziL. PassalacquaG. CanonicaG.W. Inhaled corticosteroids safety and adverse effects in patients with asthma.J. Allergy Clin. Immunol. Pract.20186377678110.1016/j.jaip.2018.01.02529408385
     [Google Scholar]
  45. YeQ. HeX.O. D’UrzoA. A review on the safety and efficacy of inhaled corticosteroids in the management of asthma.Pulm. Ther.20173111810.1007/s41030‑017‑0043‑5
     [Google Scholar]
  46. TahghighiF. ZiaeeV. The role of corticosteroids in treatment of autoimmune and rheumatologic disorders.Clinical Excellence2019843952
     [Google Scholar]
  47. MohanA. LugogoN.L. HananiaN.A. ReddelH.K. AkuthotaP. O’ByrneP.M. GuilbertT. PapiA. PriceD. JenkinsC.R. KraftM. BacharierL.B. BouletL.P. YawnB.P. PleasantsR. LazarusS.C. BeasleyR. GauvreauG. IsraelE. Schneider-FutschikE.K. YorganciogluA. MartinezF. MooreW. SuminoK. Questions in mild asthma: An official American Thoracic Society research statement.Am. J. Respir. Crit. Care Med.202320711e77e9610.1164/rccm.202304‑0642ST37260227
     [Google Scholar]
  48. ZeinJ.G. ErzurumS.C. Asthma is different in women.Curr. Allergy Asthma Rep.20151562810.1007/s11882‑015‑0528‑y26141573
     [Google Scholar]
  49. ShahR. NewcombD.C. Sex bias in asthma prevalence and pathogenesis.Front. Immunol.20189299710.3389/fimmu.2018.0299730619350
     [Google Scholar]
  50. LeynaertB. SunyerJ. Garcia-EstebanR. SvanesC. JarvisD. CerveriI. DratvaJ. GislasonT. HeinrichJ. JansonC. KuenzliN. de MarcoR. OmenaasE. RaherisonC. Gómez RealF. WjstM. ZempE. ZureikM. BurneyP.G.J. AntoJ.M. NeukirchF. Gender differences in prevalence, diagnosis and incidence of allergic and non-allergic asthma: A population-based cohort.Thorax201267762563110.1136/thoraxjnl‑2011‑20124922334535
     [Google Scholar]
  51. ChowdhuryN.U. GunturV.P. NewcombD.C. WechslerM.E. Sex and gender in asthma.Eur. Respir. Rev.20213016221006710.1183/16000617.0067‑202134789462
     [Google Scholar]
  52. KynykJ.A. MastronardeJ.G. McCallisterJ.W. Asthma, the sex difference.Curr. Opin. Pulm. Med.201117161110.1097/MCP.0b013e328341003821045697
     [Google Scholar]
  53. FuseiniH. NewcombD.C. Mechanisms driving gender differences in asthma.Curr. Allergy Asthma Rep.20171731910.1007/s11882‑017‑0686‑128332107
     [Google Scholar]
  54. De LeonibusC. AttanasiM. RozeZ. MartinB. MarcovecchioM.L. Di PilloS. ChiarelliF. MohnA. Influence of inhaled corticosteroids on pubertal growth and final height in asthmatic children.Pediatr. Allergy Immunol.201627549950610.1111/pai.1255826919136
     [Google Scholar]
  55. LokeY.K. BlancoP. ThavarajahM. WilsonA.M. Impact of inhaled corticosteroids on growth in children with asthma: Systematic review and meta-analysis.PLoS One2015107e013342810.1371/journal.pone.013342826191797
     [Google Scholar]
  56. KimS.H. SutherlandE.R. GelfandE.W. Is there a link between obesity and asthma?Allergy Asthma Immunol. Res.20146318919510.4168/aair.2014.6.3.18924843792
     [Google Scholar]
  57. SharmaV. CowanD.C. Obesity, inflammation, and severe asthma: An update.Curr. Allergy Asthma Rep.202121124610.1007/s11882‑021‑01024‑934921631
     [Google Scholar]
  58. LangJ.E. Obesity, nutrition, and asthma in children.Pediatr. Allergy Immunol. Pulmonol.2012252647510.1089/ped.2011.013722768385
     [Google Scholar]
  59. AhmadiafsharA. TabbekhhaS. MousavinasabN. KhoshnevisP. Relation between asthma and body mass index in 6-15 years old children.Acta Med. Iran.201351961561924338192
     [Google Scholar]
  60. SalvatoniA. NosettiL. NespoliL. BrogginiM. Body composition and growth in asthmatic children treated with inhaled steroids.Ann. Allergy Asthma Immunol.200085322122610.1016/S1081‑1206(10)62470‑211030277
     [Google Scholar]
  61. Daldaban SaricaB. KöksalB.T. TekindalM.A. Yilmaz ÖzbekÖ. Effect of inhaled corticosteroid treatment on body composition parameters in children with asthma.Asthma Allergy Immunol202119314915510.21911/aai.634
     [Google Scholar]
  62. Van RaalteD.H. OuwensD.M. DiamantM. Novel insights into glucocorticoid-mediated diabetogenic effects: Towards expansion of therapeutic options?Eur. J. Clin. Invest.2009392819310.1111/j.1365‑2362.2008.02067.x19200161
     [Google Scholar]
  63. YücelO. EkerY. NuhogluC. CeranO. Hemoglobin a1c levels in children with asthma using low dose inhaled corticosteroids.Indian Pediatr.200946430030319179741
     [Google Scholar]
  64. LodhaR. KabraS.K. Do inhaled corticosteroids adversely influence glucose metabolism.Indian Pediatr.200946429329419383989
     [Google Scholar]
  65. GopinathS. MurukesanP. PtR. A prospective and observational study on the variation in Hemoglobin A1c levels among asthmatic children using inhaled corticosteroids.Natl. J. Physiol. Pharm. Pharmacol.2022120110.5455/njppp.2022.12.05240202226052022
     [Google Scholar]
  66. KunøeA. SevelstedA. ChawesB.L. StokholmJ. EliasenA. KrakauerM. BønnelykkeK. BisgaardH. Associations between inhaled corticosteroid use in the first 6 years of life and obesity-related traits.Am. J. Respir. Crit. Care Med.2021204664265010.1164/rccm.202009‑3537OC33975528
     [Google Scholar]
  67. EgbuonuF. AntonioF.A. EdavalathM. Effect of inhaled corticosteroids on glycemic status.Open Respir. Med. J.20148110110510.2174/187430640140801010125674180
     [Google Scholar]
  68. MorrisT.S. AutryE.B. KuhnR.J. The role of biologics in the management of asthma in the pediatric patient.J. Pediatr. Pharmacol. Ther.202126542743610.5863/1551‑6776‑26.5.42734239393
     [Google Scholar]
  69. AndrenacciB. FerranteG. RobertoG. PiacentiniG. La GruttaS. MarsegliaG.L. LicariA. Challenges in uncontrolled asthma in pediatrics: Important considerations for the clinician.Expert Rev. Clin. Immunol.202218880782110.1080/1744666X.2022.209318735730635
     [Google Scholar]
  70. PapadopoulosN.G. ČustovićA. CabanaM.D. DellS.D. DeschildreA. HedlinG. HossnyE. Le SouëfP. MatricardiP.M. NietoA. PhipatanakulW. PitrezP.M. PohunekP. GavornikovaM. JaumontX. PriceD.B. Pediatric asthma: An unmet need for more effective, focused treatments.Pediatr. Allergy Immunol.201930171610.1111/pai.1299030312503
     [Google Scholar]
  71. CôtéA. GodboutK. BouletL.P. The management of severe asthma in 2020.Biochem. Pharmacol.202017911411210.1016/j.bcp.2020.11411232598948
     [Google Scholar]
  72. HeidariS. MohammadiS. FathiM. CigaryS. AlisamirM. MirkarimiM. AminzadehM. Association of vitamin D status with COVID-19 disease severity in pediatric patients: A retrospective observational study.Health Sci. Rep.202253e56910.1002/hsr2.56935415272
     [Google Scholar]
  73. HeidariS. TorabizadehM. ShokouhifarS. HeidariS. MirkarimiM. AlisamirM. MohammadiS. Association of asthma with COVID-19 disease severity in pediatric patients.Curr. Respir. Med. Rev.202218429730510.2174/1573398X18666220819153000
     [Google Scholar]
  74. MirkarimiM. AlisamirM. SarafS. HeidariS. BaroutiS. MohammadiS. Clinical and epidemiological determinants of lower respiratory tract infections in hospitalized pediatric patients.Int. J. Pediatr.202020201710.1155/2020/884442033281906
     [Google Scholar]
  75. MirkarimiM. AlisamirM. NasiriP. BaroutiS. MohammadiS. Determinants of complicated pneumonia in hospitalized pediatric patients.Acta Med. Iran.2021202115516010.18502/acta.v59i3.5786
     [Google Scholar]
/content/journals/crmr/10.2174/011573398X321966240816091814
Loading
Effects of Long-Term Inhaled Corticosteroid Therapy on Metabolic And Anthropometric Parameters in Pediatric Patients with Asthma
Current Respiratory Medicine Reviews 21, 159 (2025); https://doi.org/10.2174/011573398X321966240816091814
/content/journals/crmr/10.2174/011573398X321966240816091814
/content/journals/crmr/10.2174/011573398X321966240816091814
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): anthropometric; Asthma; glycemic, ICSs; lipid profile; pediatric patients

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test